Peapod Lane Capital’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-564,572
Closed -$466K 61
2025
Q1
$466K Buy
564,572
+1,952
+0.3% +$1.88K 0.52% 56
2024
Q4
$534K Buy
+562,620
New +$531K 0.53% 54

Peapod Lane Capital's KRON Position: Q2 2025 in Review

Peapod Lane Capital sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 564,572 shares — an estimated $466K sold.

Peapod Lane Capital first reported a position in KRON in Q4 2024 and held it in 2 quarters. The position peaked at $534K in Q4 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

  • Peapod Lane Capital reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
  • Peapod Lane Capital sold 564,572 Kronos Bio shares in Q2 2025, an estimated $466K.
  • Peapod Lane Capital first reported a position in Kronos Bio in Q4 2024 and held it in 2 quarters.
  • Peapod Lane Capital's Kronos Bio position peaked at $534K in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Peapod Lane Capital's 13F filing for Q2 2025, filed 31 Jul 2025.